Search research articles
Contact Us
Filters
Showing results (341-350 of 366) with videos related to
Page
of 37
Sort By:
Der Pathologe
|
July 17, 2004
[Proposal for the classification of the periprosthetic membrane from loosened hip and knee endoprostheses]
L Morawietz, Th Gehrke, R-A Classen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 3, 2024
PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms
Albert Grass, Atsuko Kasajima, Sebastian Foersch, et al.
Developmental Cell
|
June 20, 2018
Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer
Maximilian Reichert, Basil Bakir, Leticia Moreira, et al.
Cancers
|
August 23, 2020
Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, et al.
The Journal of Clinical Investigation
|
August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Honglin Jiang, Robert J Torphy, Katja Steiger, et al.
Trials
|
September 15, 2023
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD
Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann, et al.
Pathology Oncology Research : POR
|
August 6, 2020
Prevalence of APC and PTEN Alterations in Urachal Cancer
Nikolett Nagy, Henning Reis, Boris Hadaschik, et al.
Journal of Clinical Pathology
|
May 30, 2006
Proposal for a histopathological consensus classification of the periprosthetic interface membrane
L Morawietz, R-A Classen, J H Schröder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma
S M Dieter, C Heining, A Agaimy, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 5, 2021
Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field
Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 366) with videos related to
Sort By:
Page
of 37
Der Pathologe
|
July 17, 2004
[Proposal for the classification of the periprosthetic membrane from loosened hip and knee endoprostheses]
L Morawietz, Th Gehrke, R-A Classen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 3, 2024
PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms
Albert Grass, Atsuko Kasajima, Sebastian Foersch, et al.
Developmental Cell
|
June 20, 2018
Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer
Maximilian Reichert, Basil Bakir, Leticia Moreira, et al.
Cancers
|
August 23, 2020
Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, et al.
The Journal of Clinical Investigation
|
August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Honglin Jiang, Robert J Torphy, Katja Steiger, et al.
Trials
|
September 15, 2023
Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD
Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann, et al.
Pathology Oncology Research : POR
|
August 6, 2020
Prevalence of APC and PTEN Alterations in Urachal Cancer
Nikolett Nagy, Henning Reis, Boris Hadaschik, et al.
Journal of Clinical Pathology
|
May 30, 2006
Proposal for a histopathological consensus classification of the periprosthetic interface membrane
L Morawietz, R-A Classen, J H Schröder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma
S M Dieter, C Heining, A Agaimy, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 5, 2021
Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field
Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, et al.
Page
of 37